Skip to main content

Table 2 Assesment of outcomes according to groups and total number of patients

From: The effectiveness of lixisenatide as an add on therapy to basal insulin in diabetic type 2 patients previously treated with different insulin regimes: a multi-center observational study

Type of insulin regime Outcome n % p value
Premix Decrease in both BMI and HbA1c < 7% 15 13.5  
Decrease in body weight 45 40.9 NS
Decrease in HbA1c < 7 16 14.5  
Basal Decrease in both BMI and HbA1c < 7% 10 9  
Decrease in body weight 39 35.5 NS
Decrease in HbA1c < 7 13 11.8  
Basal bolus Decrease in both BMI and HbA1c < 7% 5 4.5  
Decrease in body weight 15 13.5 NS
Decrease in HbA1c < 7 5 4.5  
  1. BMI body mass index, NS not significant